228 related articles for article (PubMed ID: 37299457)
1. Early Life Obesity Increases Neuroinflammation, Amyloid Beta Deposition, and Cognitive Decline in a Mouse Model of Alzheimer's Disease.
So SW; Fleming KM; Nixon JP; Butterick TA
Nutrients; 2023 May; 15(11):. PubMed ID: 37299457
[TBL] [Abstract][Full Text] [Related]
2. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model.
Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA
J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064
[TBL] [Abstract][Full Text] [Related]
3. High Fat Diet Mediates Amyloid-β Cleaving Enzyme 1 Phosphorylation and SUMOylation, Enhancing Cognitive Impairment in APP/PS1 Mice.
Bao J; Liang Z; Gong X; Yu J; Xiao Y; Liu W; Wang X; Wang JZ; Shu X
J Alzheimers Dis; 2022; 85(2):863-876. PubMed ID: 34864680
[TBL] [Abstract][Full Text] [Related]
4. High fat diet worsens Alzheimer's disease-related behavioral abnormalities and neuropathology in APP/PS1 mice, but not by synergistically decreasing cerebral blood flow.
Bracko O; Vinarcsik LK; Cruz Hernández JC; Ruiz-Uribe NE; Haft-Javaherian M; Falkenhain K; Ramanauskaite EM; Ali M; Mohapatra A; Swallow MA; Njiru BN; Muse V; Michelucci PE; Nishimura N; Schaffer CB
Sci Rep; 2020 Jun; 10(1):9884. PubMed ID: 32555372
[TBL] [Abstract][Full Text] [Related]
5. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H
J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800
[TBL] [Abstract][Full Text] [Related]
6. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
7. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
8. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
[TBL] [Abstract][Full Text] [Related]
9. Reversal of high fat diet-induced obesity improves glucose tolerance, inflammatory response, β-amyloid accumulation and cognitive decline in the APP/PSEN1 mouse model of Alzheimer's disease.
Walker JM; Dixit S; Saulsberry AC; May JM; Harrison FE
Neurobiol Dis; 2017 Apr; 100():87-98. PubMed ID: 28108292
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Stress Alters Antioxidant Systems, Suppresses the Adiponectin Receptor 1 and Induces Alzheimer's Like Pathology in Mice Brain.
Hahm JR; Jo MH; Ullah R; Kim MW; Kim MO
Cells; 2020 Jan; 9(1):. PubMed ID: 31963819
[TBL] [Abstract][Full Text] [Related]
11. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
[TBL] [Abstract][Full Text] [Related]
12. Partial Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and Amyloid Pathology in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.
Ahmed S; Jing Y; Mockett BG; Zhang H; Abraham WC; Liu P
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806318
[TBL] [Abstract][Full Text] [Related]
13. The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease.
Zhu S; Wang J; Zhang Y; He J; Kong J; Wang JF; Li XM
CNS Neurosci Ther; 2017 Apr; 23(4):310-320. PubMed ID: 28191738
[TBL] [Abstract][Full Text] [Related]
14. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.
Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M
Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458
[TBL] [Abstract][Full Text] [Related]
15. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
Lecordier S; Pons V; Rivest S; ElAli A
Front Immunol; 2021; 12():813536. PubMed ID: 35173711
[TBL] [Abstract][Full Text] [Related]
16. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
[TBL] [Abstract][Full Text] [Related]
17. CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes.
Jiang H; Niu F; Zheng Y; Xu Y
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604684
[TBL] [Abstract][Full Text] [Related]
18. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Naert G; Rivest S
J Neurosci; 2011 Apr; 31(16):6208-20. PubMed ID: 21508244
[TBL] [Abstract][Full Text] [Related]
19. Chronic sleep deprivation exacerbates cognitive and synaptic plasticity impairments in APP/PS1 transgenic mice.
Wang C; Gao WR; Yin J; Wang ZJ; Qi JS; Cai HY; Wu MN
Behav Brain Res; 2021 Aug; 412():113400. PubMed ID: 34087256
[TBL] [Abstract][Full Text] [Related]
20. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
